Last reviewed · How we verify
NCT07522931: RETRO-PELVIS
Morphometric Study of the Female Pelvic and Lower Abdominal Retroperitoneum in Cadavers
trial testing Anatomical Dissection in Pelvic Anatomy in 20 participants. Currently enrolling.
28 September 2026
Quick facts
| Lead sponsor | Hospital Universitari de Bellvitge |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 14 April 2026 |
| Primary completion | 28 September 2026 |
| Estimated completion | 30 November 2026 |
| Sites | 2 locations across Spain |
Drugs / interventions tested
- Anatomical Dissection
Conditions studied
- Pelvic Anatomy — all drugs for Pelvic Anatomy →
- Retroperitoneum — all drugs for Retroperitoneum →
- Cadaveric Study — all drugs for Cadaveric Study →
- Surgical Anatomy — all drugs for Surgical Anatomy →
Sponsor
Hospital Universitari de Bellvitge
Who can join
18 and older, female only, with Pelvic Anatomy or Retroperitoneum. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to provide a systematic anatomical and morphometric description of the female pelvic and lower abdominal retroperitoneum using cadaveric dissection, with direct application to gynecologic surgery. Standardized dissections will be performed in adult female cadavers obtained from a body donation program. Key anatomical structures, including the ureter, iliac vessels, aorta, inferior vena cava, hypogastric plexuses, and lymphatic territories, will be identified and measured. Spatial relationships, distances, and anatomical variations will be recorded using direct measurements and standardized photographic documentation. The study will quantify anatomical variability and asymmetry between right and left hemipelves, focusing on ureteral, vascular, and neural structures. The results are expected to improve surgical planning, particularly in nerve-sparing techniques and pelvic and para-aortic lymphadenectomy, and to support the development of an applied anatomical atlas for educational and clinical use.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07522931
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Hospital Universitari de Bellvitge trials
Trials by the same sponsor.
- NCT07155590 — Subphenotype- and Complication-guided Adjunctive Fosfomycin Therapy for Staphylococcus Aureus Bacteraemia · active not recruiting
- NCT06653192 — EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial) · NA · recruiting
- NCT07178483 — Evaluation of Physical Capacity and Energy Requirements in Patients With Hypoxemic Acute Respiratory Failure · active not recruiting
- NCT06955221 — Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis · NA · recruiting
- NCT06499064 — EOSS-ATTR Study (eHealth Based Operative Support System in ATTR-CM) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07522931 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Universitari de Bellvitge
- Last refreshed: 17 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07522931.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing